comparemela.com

Latest Breaking News On - Allison soss erika kay - Page 1 : comparemela.com

Mydecine to Participate in Wonderland: Miami on November 8-9, 2021

Mydecine to Participate in Wonderland: Miami on November 8-9, 2021
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Mydecine Innovations Group Announces Launch of Mindleap Version 2 0

Mydecine Innovations Group Announces Launch of Mindleap Version 2 0
financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004
leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.

Mydecine to Participate in the H C Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th

Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th 06/03/2021 | 07:30am EDT Send by mail : Message : DENVER, June 03, 2021 (GLOBE NEWSWIRE) Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today announced that Josh Bartch, CEO of Mydecine, will participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference to be hosted virtually on Thursday, June 17, 2021. Mr. Bartch’s corporate presentation will be available on-demand starting at 7:00 a.m. ET. To attend, register

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.